pubmed-article:11068101 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11068101 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:11068101 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:11068101 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:11068101 | lifeskim:mentions | umls-concept:C0034837 | lld:lifeskim |
pubmed-article:11068101 | lifeskim:mentions | umls-concept:C0063684 | lld:lifeskim |
pubmed-article:11068101 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:11068101 | lifeskim:mentions | umls-concept:C1720154 | lld:lifeskim |
pubmed-article:11068101 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:11068101 | pubmed:dateCreated | 2000-12-18 | lld:pubmed |
pubmed-article:11068101 | pubmed:abstractText | Central administration of amylin (2.2 microg/rat, i.c.v.) reduces (from a minimum of 67% to 83%) indomethacin (Indo, 20 mg Kg(-1), orally) induced ulcers in rats. The anti-ulcer effect of the peptide is not removed by the administration of prokinetic drugs like domperidone or neostigmine but it is reduced by 35% in rats treated with capsaicin or with the CGRP antagonist, CGRP(8-37). These data indicate that amylin gastroprotection involves capsaicin-sensitive nerve fiber leading to CGRP-dependent gastric vasodilatory effect. Additional mechanisms could involve noradrenergic alpha(2) receptors as the peptide gastroprotective activity is reduced from 67% to 20% by the alpha(2) antagonist yohimbine. | lld:pubmed |
pubmed-article:11068101 | pubmed:language | eng | lld:pubmed |
pubmed-article:11068101 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11068101 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11068101 | pubmed:month | Oct | lld:pubmed |
pubmed-article:11068101 | pubmed:issn | 0196-9781 | lld:pubmed |
pubmed-article:11068101 | pubmed:author | pubmed-author:NettiCC | lld:pubmed |
pubmed-article:11068101 | pubmed:author | pubmed-author:GuidobonoFF | lld:pubmed |
pubmed-article:11068101 | pubmed:author | pubmed-author:PaganiFF | lld:pubmed |
pubmed-article:11068101 | pubmed:author | pubmed-author:SibiliaVV | lld:pubmed |
pubmed-article:11068101 | pubmed:author | pubmed-author:RapettiDD | lld:pubmed |
pubmed-article:11068101 | pubmed:author | pubmed-author:SoglianAA | lld:pubmed |
pubmed-article:11068101 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11068101 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:11068101 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11068101 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11068101 | pubmed:pagination | 1537-41 | lld:pubmed |
pubmed-article:11068101 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:meshHeading | pubmed-meshheading:11068101... | lld:pubmed |
pubmed-article:11068101 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:11068101 | pubmed:articleTitle | The role of sensory neurons in the antiulcer effect of centrally injected amylin in rat. | lld:pubmed |
pubmed-article:11068101 | pubmed:affiliation | Department of Pharmacology, Chemotherapy and Medical Toxicology, University of Milan, Via Vanvitelli 32, 20129, Milano, Italy. guidobon@mailserver.unimi.it | lld:pubmed |
pubmed-article:11068101 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11068101 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |